東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

High density lipoproteins = from bio...

Eckardstein, Arnold von.

FindBook

Google Book

Amazon

博客來

High density lipoproteins = from biological understanding to clinical exploitation /

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	High density lipoproteins/ edited by Arnold von Eckardstein, Dimitris Kardassis.
其他題名:	from biological understanding to clinical exploitation /
其他作者:	Eckardstein, Arnold von.
出版者:	Cham :Springer International Publishing : : 2015.,
面頁冊數:	xiii, 694 p. :ill. (some col.), digital ;24 cm.
內容註:	Preface -- Part 1. Physiology of HDL -- Part 2. Pathology of HDL -- Part 3. Possible Indications and Target Mechanisms of HDL Therapy -- Part 4. Treatments for Dyslipidemias and Dysfunction of HDL.
Contained By:	Springer eBooks
標題:	High density lipoproteins. -
電子資源:	http://dx.doi.org/10.1007/978-3-319-09665-0
ISBN:	9783319096650 (electronic bk.)

High density lipoproteins = from biological understanding to clinical exploitation /
High density lipoproteinsfrom biological understanding to clinical exploitation /[electronic resource] :edited by Arnold von Eckardstein, Dimitris Kardassis. - Cham :Springer International Publishing :2015. - xiii, 694 p. :ill. (some col.), digital ;24 cm. - Handbook of experimental pharmacology,v.2240171-2004 ;. - Handbook of experimental pharmacology ;208..

Preface -- Part 1. Physiology of HDL -- Part 2. Pathology of HDL -- Part 3. Possible Indications and Target Mechanisms of HDL Therapy -- Part 4. Treatments for Dyslipidemias and Dysfunction of HDL.

In this Handbook of Experimental Pharmacology on High Density Lipoproteins from biological understanding to clinical exploitation contributing authors (members of COST Action BM0904/HDLnet) summarize in more than 20 chapters our current knowledge on the structure, function, metabolism and regulation of HDL in health and several diseases as well as the status of past and ongoing attempts of therapeutic exploitation. The book is of interest to researchers in academia and industry focusing on lipoprotein metabolism, cardiovascular diseases and immunology as well as clinical pharmacologists, cardiologists, diabetologists, nephrologists and other clinicians interested in metabolic or inflammatory diseases.

ISBN: 9783319096650 (electronic bk.)

Standard No.: 10.1007/978-3-319-09665-0doiSubjects--Topical Terms:

1086887
High density lipoproteins.

LC Class. No.: QP99.3.H53

Dewey Class. No.: 572.68

High density lipoproteins = from biological understanding to clinical exploitation /
LDR:01999nmm a2200325 a 4500 001 1994412
003 DE-He213
005 20150729151426.0
006 m d
007 cr nn 008maaau
008 151019s2015 gw s 0 eng d
020 $a 9783319096650 (electronic bk.)
020 $a 9783319096643 (paper)
024 7 $a 10.1007/978-3-319-09665-0 $2 doi
035 $a 978-3-319-09665-0
040 $a GP $c GP
041 0 $a eng
050 4 $a QP99.3.H53
072 7 $a MMG $2 bicssc
072 7 $a MED071000 $2 bisacsh
082 0 4 $a 572.68 $2 23
090 $a QP99.3.H53 $b H638 2015
245 0 0 $a High density lipoproteins $h [electronic resource] : $b from biological understanding to clinical exploitation / $c edited by Arnold von Eckardstein, Dimitris Kardassis.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2015.
300 $a xiii, 694 p. : $b ill. (some col.), digital ; $c 24 cm.
490 1 $a Handbook of experimental pharmacology, $x 0171-2004 ; $v v.224
505 0 $a Preface -- Part 1. Physiology of HDL -- Part 2. Pathology of HDL -- Part 3. Possible Indications and Target Mechanisms of HDL Therapy -- Part 4. Treatments for Dyslipidemias and Dysfunction of HDL.
520 $a In this Handbook of Experimental Pharmacology on High Density Lipoproteins from biological understanding to clinical exploitation contributing authors (members of COST Action BM0904/HDLnet) summarize in more than 20 chapters our current knowledge on the structure, function, metabolism and regulation of HDL in health and several diseases as well as the status of past and ongoing attempts of therapeutic exploitation. The book is of interest to researchers in academia and industry focusing on lipoprotein metabolism, cardiovascular diseases and immunology as well as clinical pharmacologists, cardiologists, diabetologists, nephrologists and other clinicians interested in metabolic or inflammatory diseases.
650 0 $a High density lipoproteins. $3 1086887
650 1 4 $a Biomedicine. $3 890831
650 2 4 $a Pharmacology/Toxicology. $3 890953
650 2 4 $a Molecular Medicine. $3 890952
650 2 4 $a Human Physiology. $3 894102
650 2 4 $a Immunology. $3 611031
650 2 4 $a Cell Biology. $3 892383
700 1 $a Eckardstein, Arnold von. $3 2133216
700 1 $a Kardassis, Dimitris. $3 2133217
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer eBooks
830 0 $a Handbook of experimental pharmacology ; $v 208. $3 1567347
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-09665-0
950 $a Biomedical and Life Sciences (Springer-11642)